Chescapmanager’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-47,281
Closed -$524K 32
2024
Q3
$524K Hold
47,281
0.06% 26
2024
Q2
$439K Hold
47,281
0.04% 27
2024
Q1
$1.55M Sell
47,281
-1,389
-3% -$45.5K 0.15% 28
2023
Q4
$1.3M Sell
48,670
-125
-0.3% -$3.34K 0.13% 23
2023
Q3
$2.95M Buy
48,795
+2,807
+6% +$170K 0.38% 23
2023
Q2
$4.69M Buy
45,988
+13,755
+43% +$1.4M 0.73% 22
2023
Q1
$5.7M Hold
32,233
0.9% 21
2022
Q4
$12.5M Hold
32,233
2.92% 11
2022
Q3
$10.9M Hold
32,233
2.53% 12
2022
Q2
$10.6M Sell
32,233
-417
-1% -$137K 2.5% 11
2022
Q1
$14.3M Sell
32,650
-3,597
-10% -$1.57M 1.94% 14
2021
Q4
$15.9M Hold
36,247
2.12% 17
2021
Q3
$20.2M Buy
36,247
+8
+0% +$4.45K 2.86% 9
2021
Q2
$18.6M Sell
36,239
-278
-0.8% -$143K 2.04% 10
2021
Q1
$28.5M Hold
36,517
3.04% 6
2020
Q4
$19.9M Buy
36,517
+9
+0% +$4.9K 2.42% 11
2020
Q3
$16.7M Sell
36,508
-4,723
-11% -$2.16M 2.7% 15
2020
Q2
$25.4M Buy
41,231
+4,970
+14% +$3.06M 4.27% 4
2020
Q1
$17.2M Buy
36,261
+158
+0.4% +$75.1K 4.22% 11
2019
Q4
$20.9M Buy
36,103
+1,597
+5% +$926K 3.08% 12
2019
Q3
$22.7M Buy
34,506
+3,889
+13% +$2.56M 3.23% 8
2019
Q2
$23.7M Sell
30,617
-2,801
-8% -$2.17M 2.36% 7
2019
Q1
$23.6M Sell
33,418
-45
-0.1% -$31.8K 2.8% 6
2018
Q4
$15.7M Hold
33,463
3.78% 10
2018
Q3
$28.9M Buy
33,463
+1,118
+3% +$964K 2.96% 3
2018
Q2
$22.3M Buy
32,345
+3,097
+11% +$2.14M 2.58% 7
2018
Q1
$13M Buy
29,248
+555
+2% +$247K 1.94% 16
2017
Q4
$12.6M Buy
28,693
+279
+1% +$123K 2.06% 14
2017
Q3
$14M Buy
28,414
+125
+0.4% +$61.6K 2.72% 12
2017
Q2
$15.7M Buy
28,289
+3,473
+14% +$1.92M 2.64% 6
2017
Q1
$16.4K Buy
24,816
+5,784
+30% +$3.83K 2.25% 4
2016
Q4
$6.37M Buy
+19,032
New +$6.37M 2.34% 16